Melanoma, Mucosal
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I) (NCT05169957) | University of Michigan Rogel Cancer Center | 2022-08-09 |
| Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy (NCT04904120) | Perspective Therapeutics | 2021-03-05 |
Track Melanoma, Mucosal automatically
Every clearance here is in the API, with alerts when new ones post.